Pharmacy benefit considerations for continuous glucose monitoring acquisition: Vermont Medicaid

被引:0
作者
Hurteau, Lisa Brouillette [1 ]
Hogue, Nancy J. [2 ]
机构
[1] Dept Vermont Hlth Access, Waterbury, VT 05671 USA
[2] Blue Cross & Blue Shield Vermont, Berlin, VT USA
关键词
QUALITY-OF-LIFE; GLYCEMIC CONTROL; DIABETIC-KETOACIDOSIS; INSULIN INJECTIONS; TYPE-1; ADULTS; HYPOGLYCEMIA; TECHNOLOGY; YOUTH; CARE;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Many individuals with diabetes are not achieving their glycemic goals. Use of continuous glucose monitoring (CGM) improves diabetes management. Access to CGM is often hindered when individuals must acquire their supplies through the traditional durable medical device chan-nel. Vermont Medicaid transitioned CGM coverage from a medical/durable medical equipment benefit to a pharmacy benefit. This improved access and lessened the burden on prescribing health care provid-ers. We describe the process the Vermont Medicaid program implemented to make this transition.
引用
收藏
页码:550 / 556
页数:7
相关论文
共 34 条
[31]   THE EFFECT OF LONG-TERM INTENSIFIED INSULIN-TREATMENT ON THE DEVELOPMENT OF MICROVASCULAR COMPLICATIONS OF DIABETES-MELLITUS [J].
REICHARD, P ;
NILSSON, BY ;
ROSENQVIST, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) :304-309
[32]  
Rx Impact, 2015, COMM PHARM FAC NEIGH
[33]  
Vermont Department of Health, 2022, DIABETES SURVEILLANC
[34]   Effect of improved glycemic control on health care costs and utilization [J].
Wagner, EH ;
Sandhu, N ;
Newton, KM ;
McCulloch, DK ;
Ramsey, SD ;
Grothaus, LC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (02) :182-189